Ascendis Pharma A/S (ASND)
242.16
+8.66
(+3.71%)
USD |
NASDAQ |
Mar 02, 16:00
242.16
0.00 (0.00%)
After-Hours: 20:00
Ascendis Pharma EPS Diluted (Quarterly) : -0.6364 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Novo Nordisk A/S | 0.9419 |
| Evaxion AS | -0.2862 |
| DBV Technologies SA | -1.207 |
| Cellectis SA | 0.0058 |
| Biodexa Pharmaceuticals Plc | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -39.06M |
| Revenue (Quarterly) | 288.07M |
| Total Expenses (Quarterly) | 327.14M |
| Enterprise Value | 14.63B |
| Gross Profit Margin (Quarterly) | 88.91% |
| Profit Margin (Quarterly) | -13.56% |
| Earnings Yield | -1.73% |
| Normalized Earnings Yield | -1.733 |